Skip to main content
. 2021 Jul 28;18(15):7966. doi: 10.3390/ijerph18157966

Table 1.

Comparison of National (US) and Nevada-specific incidence rates of oral and pharyngeal, esophageal, and lung cancers.

Nevada United States (US)
Incidence (all cancer)
(95% Confidence Intervals)
−1.6%
(−1.9, −1.2)
−1.0%
(−1.2, −0.8)
Oral Cancer-Incidence 0.0%
(−0.6, 0.6)
−0.9%
(−3.8, 2.1)
Race—White (not Hispanic) 0.6%
(0.0. 1.2)
−0.6%
(−3.7, 2.5)
Race—Black (plus Hispanic) * Insufficient data −1.7%
(−1.9, −1.4)
Sex—Male 0.0%
(−0.7, 0.7)
0.8%
(0.6, 1.0)
Sex—Female 0.0%
(−1.5, 1.5)
0.4%
(0.2, 0.5)
Esophagus Cancer-Incidence −1.5%
(−2.9, −0.2)
−1.1%
(−1.4, −0.9)
Race—White (not Hispanic) −0.9%
(−2.2, −0.4)
−0.5%
(−0.8, −0.2)
Race—Black (plus Hispanic) * Insufficient data −4.3%
(−4.5, −4.1)
Sex—Male −1.3%
(−2.8, −0.3)
−0.8%
(−1.5, −0.2)
Sex—Female −2.5%
(−4.9, −0.1)
−1.3%
(−1.5, −1.1)
Lung Cancer-Incidence −3.2%
(−3.6, −2.8)
−2.0%
(−2.2, −1.9)
Race—White (not Hispanic) −3.0%
(−3.5, −2.6)
−1.8%
(−2.0, −1.6)
Race—Black (plus Hispanic) −2.1%
(−3.1, −1.1)
−2.6%
(−3.0, −2.3)
Sex—Male −3.9%
(−4.5, −3.2)
−2.8%
(−2.9, −2.6)
Sex—Female −2.6%
(−3.0, −2.2)
−1.3%
(−1.5, −1.1)

* Note: Due to differing state reporting requirements some demographic data may be missing resulting in “insufficient data”.